Mederma

What Mederma does

Mederma is an over-the-counter dermatological brand specializing in scar treatment, stretch mark therapy, and adjacent skin-care products, serving consumers seeking clinically recommended topical solutions for post-surgical scars, injury-related scarring, stretch marks during and after pregnancy, pediatric scar care, and cold sore management. The company's portfolio is anchored by its Triple-Action Formula built around the proprietary Cepalin (onion extract) ingredient, combined with allantoin, hyaluronic acid, niacinamide, and vitamin E; the cold sore patch SKU is built on proprietary Hydrocolloid-075 Technology.

Mederma operates a consumer health go-to-market model: products are sold at premium OTC price points (e.g., $19.99-$39.99 ranges visible across SKUs) through US mass and drug retail (CVS, Rite Aid, Walgreens, Target, Walmart) and Amazon, with international distribution extending into Canada, Mexico, the UK, and several APAC markets including Malaysia, Thailand, Hong Kong, Taiwan, Sri Lanka, and Bangladesh. The brand is positioned as the #1 Doctor and Pharmacist Recommended Brand for Scar Treatment based on the IQVIA ProVoice Survey (April 2022), which is the central commercial asset used to drive point-of-care recommendation and consumer pull.

The business is privately held as a brand but operates under Perrigo Company plc (NYSE: PRGO), a public consumer healthcare platform that acquired Mederma through the 2014 purchase of the Omega Pharma business; Mederma's headcount is reported at 101-250 employees, with operational roots in Raleigh, North Carolina. Growth is driven by SKU portfolio expansion (Kids line, SPF 30, Cold Sore Patch, Stretch Marks Therapy) and geographic reach rather than disclosed M&A, funding rounds, or leadership turnover in the available data.

Name

Mederma

Legal name

Mederma

Website

https://mederma.com

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

Mederma is an OTC dermatology brand that sells scar and stretch mark treatments, a kids scar gel, and a cold sore patch through US drug and mass retail and international channels, positioned as the #1 doctor- and pharmacist-recommended scar brand under Perrigo.

Ownership category

akta.pro rank

Product category

Consumer Skincare / OTC Dermatological Products

NAICS

Cosmetics, Beauty Supplies, and Perfume Retailers (456120), Health and Personal Care Retailers (4561), Health and Personal Care Retailers (456)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Baby Skincare (Lotions, Creams, Oils) (CRABAJAB)

Keywords

• Scar treatment products
• Stretch mark therapy
• Cold sore patches
• Over-the-counter skincare
• Consumer dermatological products

Headquarters

HQ city

Raleigh

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D

Revenue model

1. Consumer Skincare Products: Mederma generates revenue through the sale of over-the-counter skincare products for scar treatment, stretch mark therapy, and cold sore care. Products are sold as one-time purchases through retail pharmacies, online retailers, and direct-to-consumer e-commerce. The product line includes gels, creams, oils, and hydrocolloid patches in various sizes targeting different consumer needs.

Pricing tiers

Go-to-market motion1 record

Distribution channels7 records

Marketing channels4 records

Core offering

Mederma sells over-the-counter topical skincare products for scar treatment, stretch mark therapy, and cold sore care, including scar gels, creams (including SPF and overnight variants), scar serums, self-adhesive scar sheets, stretch mark therapy creams and oils, and hydrocolloid cold sore healing patches. The brand is positioned as the #1 dermatologist- and plastic surgeon-recommended scar product line and is targeted at adults, kids, and pregnant/postpartum consumers.

Product overview

Mederma is a dermatological skincare brand offering a portfolio of over-the-counter topical treatments for scars, stretch marks, and cold sores. The core product line is built around a proprietary triple-action formula featuring Cepalin (onion extract), allantoin, and various combinations of hyaluronic acid, niacinamide, vitamin E, and peptides. The scar treatment portfolio includes gels (Advanced Scar Gel, for Kids), creams (Scar Cream Plus SPF 30, PM Intensive Overnight Scar Cream), a scar serum, and scar sheets. For stretch marks, the brand offers Stretch Marks Therapy cream and Quick Dry Oil. The cold sore line features the Discreet Healing Patch utilizing Hydrocolloid-075 technology. All products are distributed through major retail channels including Amazon, CVS, Rite Aid, Target, Walgreens, and Walmart.

Differentiator

Problem solved

Functional benefit

Products and services

• Mederma Advanced Scar Gel
• Mederma Scar Cream Plus SPF 30
• Mederma PM Intensive Overnight Scar Cream
• Mederma for Kids
• Mederma Scar Sheet (Small)
• Mederma Scar Serum
• Mederma Stretch Marks Therapy
• Mederma Quick Dry Oil
• Mederma Cold Sore Discreet Healing Patch

Quantifiable outcome

• 65% of patients using Mederma Cold Sore Patch reported faster healing compared to usual cold sore treatment
• +2 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• CeraVe: CeraVe (L'Oréal) is a broad dermatological skincare incumbent that competes with Mederma's treatment serums and creams across pharmacies and mass retailers. While not a scar specialist, its niacinamide- and ceramide-based portfolio encroaches on Mederma's ingredient positioning and HCP endorsement channel.
• Eucerin: Eucerin (Beiersdorf) is a broad dermatological skincare incumbent with stretch mark and body repair products sold through the same pharmacy retailers. It competes with Mederma's Stretch Marks Therapy and PM Overnight cream on ingredient credibility and HCP endorsement.
• La Roche-Posay: La Roche-Posay (L'Oréal) is a broad dermatological skincare incumbent with a deep scar and post-procedure portfolio (Cicaplast, B5 baume). It competes for the same dermatologist recommendation share and premium pharmacy shelf placement as Mederma.

Emerging players

• SkinMedica: SkinMedica (Allergan Aesthetics) is a treatment skincare brand with peptide- and growth-factor-based serums and post-procedure products. It overlaps with Mederma's PM Intensive Overnight Scar Cream in the professional-channel and post-procedure skincare space.
• Hero Cosmetics (Mighty Patch): Hero Cosmetics' Mighty Patch is a hydrocolloid patch product that has expanded from acne into the broader pimple and skin recovery category. While primarily an acne patch, its brand and product architecture overlap with Mederma's Cold Sore Discreet Healing Patch technology and consumer demographic.
• Differin (Galderma): Differin (Galderma) is an OTC acne treatment brand whose users commonly develop acne scars, a primary use case for Mederma's scar products. The brands share retail channels and partially overlapping consumer journeys even though Differin does not directly treat scars.

Direct peers

• Compeed: Compeed (Johnson & Johnson) is the leading hydrocolloid cold sore patch brand and the closest direct competitor to Mederma's Cold Sore Discreet Healing Patch. Both products use hydrocolloid technology to accelerate healing and provide 12-hour protection in the same cold sore category.
• Bio-Oil: Bio-Oil is a direct competitor in scar and stretch mark skincare, selling a multi-use specialty oil with a similar Cepalin-adjacent positioning and identical retail channels. It is the most directly comparable brand in Mederma's stretch mark and scar treatment categories.
• ScarAway: ScarAway is a direct peer in the OTC scar treatment category, with silicone scar sheets and gels distributed through the same pharmacy and mass retailers. Its product mix and use cases (surgical, injury, and acne scars) overlap almost entirely with Mederma's core scar gel and scar sheet lines.
• Palmer's: Palmer's is a direct peer in stretch mark and body skincare, with cocoa butter-based oils and creams sold in identical mass and pharmacy channels. It competes most directly with Mederma Stretch Marks Therapy and Quick Dry Oil.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks1 record

Key highlights7 records

Customer concentration

• Xx.com/mederma
• Facebookfacebook.com/Mederma
• LinkedInlinkedin.com/company/mederm

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mederma